Causes of chronic retention of urine in the primary care setting

Internal Medicine

Volumn 44, Issue 7, 2005, Pages 761-762

  Kurasawa, Gotaro ^a   Kotani, Kazuhiko ^a   Kurasawa, Miwa ^b   Takama, Noriaki ^b   Orimo, Kenichiro ^b  

^a Nishiagatsuma Welfare Hospital   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Drug induced urinary retention; Dysuria; Overflow incontinence

Indexed keywords

AMITRIPTYLINE; ANTIVIRUS AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; EPERISONE; MUSCLE RELAXANT AGENT; OXYBUTYNIN; PROPIVERINE; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; BLADDER CATHETERIZATION; BRAIN DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSURIA; ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PROSTATE DISEASE; RESIDUAL URINE; SPINE DISEASE; URINARY FREQUENCY; URINE INCONTINENCE; URINE RETENTION;

AGED; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; URINARY RETENTION;

EID: 23244433375     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.761     Document Type: Article

References (5)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 21: 167-178, 2002.
2. Peggs JF. Urinary incontinence in the elderly: Pharmacologic therapies. Am Fam Physician 46: 1763-1769, 1992.
3. Finkelstein MM. Medical conditions, medications, and urinary incontinence: Analysis of a population-based survey. Can Fam Physician 48: 96-101, 2002.
4. Drake MJ, Nixon PM, Crew JP. Drug-induced bladder and urinary disorders. Incidence, prevention and management. Drug Safety 19: 45-55, 1998.
5. Uozumi J. Drug-induced urinary retention and its management. Journal of Integrated Medicine (JIM) 11: 421-423, 2001 (in Japanese).